LLNL researchers have developed a technology suite that includes several methods for detecting trace levels of illicit drugs even in mixtures. These methods can be used as a rapid screening test for incoming samples; for the samples that were determined to contain detectable amounts, they would undergo final verification using conventional laboratory analytical techniques.

LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals. LLNL researchers have applied their newly developed generalizable screening method to the identification of pathogenic bacteria by screening linear B-cell epitopes in the proteome of Francisella…

LLNL researchers have developed a custom resin formulation which uses a dispersing solvent and only a multifunctional monomer as the binding agent. The dispersing solvent system typically used has multiple components meant to achieve excellent dispersal of silica in order to create a flowable resin (rather than a paste). The dispersing agent has low vapor pressure, which allows the 3D printed…

LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).

LLNL has developed an approach, for formation of NLP/…